299 related articles for article (PubMed ID: 7459549)
1. Recognition of the superscan in prostatic bone scintigraphy.
Constable AR; Cranage RW
Br J Radiol; 1981 Feb; 54(638):122-5. PubMed ID: 7459549
[TBL] [Abstract][Full Text] [Related]
2. Increased skeletal:renal uptake ratio: etiology and characteristics.
Cheng TH; Holman BL
Radiology; 1980 Aug; 136(2):455-9. PubMed ID: 6447313
[TBL] [Abstract][Full Text] [Related]
3. [The early scintigraphic diagnosis of bone metastases in prostatic carcinoma].
Petrov T; Tsvetkov M; Mladenov D; Kumanov Kh
Khirurgiia (Sofiia); 1991; 44(5):28-9. PubMed ID: 1844461
[TBL] [Abstract][Full Text] [Related]
4. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
Pollen JJ; Witztum KF; Ashburn WL
AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
[TBL] [Abstract][Full Text] [Related]
5. 99Tcm-MDP and 99Tcm-DPD in pathologic bone lesions. A visual and quantitative comparison.
Lantto T; Vorne M; Mokka R; Vähätalo S
Acta Radiol; 1987; 28(5):631-3. PubMed ID: 2960361
[TBL] [Abstract][Full Text] [Related]
6. High renal activity on bone scintigrams. A sign of hypercalcaemia?
Buxton-Thomas MS; Wraight EP
Br J Radiol; 1983 Dec; 56(672):911-4. PubMed ID: 6228281
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of 99mTc-methylene diphosphonate scintigraphy of patients with lung cancer].
Abe M; Ohde R; Ogata T; Kawaguchi S; Kikuchi K; Kawai T; Matsuzawa K; Takanoshi H
Rinsho Hoshasen; 1982 Jun; 27(6):621-5. PubMed ID: 6292553
[No Abstract] [Full Text] [Related]
8. A computer assisted comparison of 99Tcm-methylene-diphosphonate and 99Tcm-pyrophosphate bone imaging.
Büll U; Pfeifer JP; Niendorf HP; Tongendorff J
Br J Radiol; 1977 Sep; 50(597):629-36. PubMed ID: 198055
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of a technetium-99m bone imaging agent based on the vicinal diphosphonate 1,2-diphosphonoethyleneglycol (DPEG).
Pauwels EK; Camps JA; Blom J; Hermans J; Kelly JD; Cumming SA; Blackburn GM; Rashid A
Nucl Med Commun; 1985 Nov; 6(11):739-45. PubMed ID: 3831848
[TBL] [Abstract][Full Text] [Related]
10. Pitfalls of absent or faint kidney sign or bone scan.
Constable AR; Cranage RW
J Nucl Med; 1981 Jul; 22(7):658. PubMed ID: 6454765
[No Abstract] [Full Text] [Related]
11. Superscan in patients with nasopharyngeal carcinoma.
Liu RS; Chu YK; Chu LS; Yeh SH; Yen SH; Chen KY; Chen YK; Shen YY
Clin Nucl Med; 1996 Apr; 21(4):302-6. PubMed ID: 8925613
[TBL] [Abstract][Full Text] [Related]
12. Coexistent Superscan and Lincoln Sign on Bone Scintigraphy.
Kulkarni M; Soni A; Shetkar S; Amer M; Mulavekar A; Joshi P
Clin Nucl Med; 2017 Aug; 42(8):630-632. PubMed ID: 28525460
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancer.
Coleman RE; Meier CA; Rubens RD; Fogelman I
Nucl Med Commun; 1988 Jul; 9(7):481-5. PubMed ID: 3173907
[TBL] [Abstract][Full Text] [Related]
14. [Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy].
Weckesser M; Müller-Mattheis VG; Vosberg H; Müller-Gärtner HW
Nuklearmedizin; 1998 Jun; 37(4):156-8. PubMed ID: 9650218
[TBL] [Abstract][Full Text] [Related]
15. Expanded 99mTc-methylene diphosphonate (MDP) bone scan.
Pollen JJ; Witztum K; Basarab R
Urology; 1984 Dec; 24(6):632-8. PubMed ID: 6239440
[TBL] [Abstract][Full Text] [Related]
16. Normal technetium 99m diphosphonate bone scintigraphy in skeletal metastases from hepatocellular carcinoma.
Maillefert JF; Tebib J; Quipourt V; Brunotte F; Michiels C; Hillon P; Tavernier C
J Hepatol; 1994 Oct; 21(4):684. PubMed ID: 7814817
[No Abstract] [Full Text] [Related]
17. [Cancer of the prostate: value of bone scintigraphy. Point of view].
Lumbroso J; Guermazi F; Wibault P; Henry-Amar M; Travagli JP
Bull Cancer; 1985; 72(5):436-41. PubMed ID: 3907735
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of routine bone scintigraphy renal imaging in renal cell carcinoma.
Chancellor MB; Konnak JW; Grossman HB
Urology; 1989 May; 33(5):440-2. PubMed ID: 2775373
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of bone metastases from carcinoma of the prostate by bone scintigraphy with 99mTc-phosphorous compounds (author's transl)].
Bussaka H; Fujimura N; Yamasaki K
Kaku Igaku; 1980 Apr; 17(3):297-303. PubMed ID: 7392308
[No Abstract] [Full Text] [Related]
20. Radionuclide bone imaging: an illustrative review.
Love C; Din AS; Tomas MB; Kalapparambath TP; Palestro CJ
Radiographics; 2003; 23(2):341-58. PubMed ID: 12640151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
